Skip to main content
. 2019 Nov 12;38:463. doi: 10.1186/s13046-019-1466-7

Fig. 7.

Fig. 7

Model depicting that PES1 interacted with BRD4 and contributed to the BET inhibitor resistance via increasing the expression levels of c-Myc in pancreatic cancer. CDK5 phosphorylated and stabilized PES1. Dinaciclib was proved to down-regulate PES1 and overcome the JQ1 resistance in pancreatic cancer cells